All In MedTech

FDA Clearance Tracker · P170029-S003

CALCIVIS Imaging System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 13, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 13, 2023

Approved

Time to decision

31 days

Received Sep 12, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P170029-S003
Device name
CALCIVIS Imaging System
Applicant location
Edinburgh
Received
Sep 12, 2023
Decided
Oct 13, 2023
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P170029

Device type

Device class
Class III

Every decision under product code QJX

FDA's approval statement

As written in FDA's record.

Approval for the CALCIVIS Imaging System is intended to be used by dental healthcare professionals on patients (6 years and older) with, or at risk of developing, demineralization associated with caries lesions, on accessible coronal tooth surfaces. The CALCIVIS Imaging System is indicated for use to provide images of active demineralization on tooth surfaces, as an aid to the assessment, diagnosis, monitoring and treatment planning of demineralization associated with caries lesions.

Source documents

Other decisions for Calcivis Limited

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.